The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 31, 2017

Filed:

Aug. 30, 2013
Applicants:

University of Maryland, Baltimore, Baltimore, MD (US);

Ucl Business Plc, London, GB;

Inventors:

Richard Thompson, Baltimore, MD (US);

Imre Lengyel, London, GB;

Assignee:

University of Maryland, Baltimore, Baltimore, MD (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); G01N 33/58 (2006.01); A61K 51/04 (2006.01); G01N 33/84 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 49/0017 (2013.01); A61K 9/0048 (2013.01); A61K 49/0004 (2013.01); A61K 51/04 (2013.01); G01N 33/582 (2013.01); G01N 33/84 (2013.01);
Abstract

Labels and methods are provided for detecting deposits, including drusen, sub-retinal deposits, basal laminar and linear deposits, and the like. The labels can detect the presence, progression, or regression of hydroxyapatite, which can be indicative of the presence or the potential to develop such deposits. The labels can include a conjugate comprising a hydroxyapatite binding moiety and a label moiety, which can provide a detectable signal upon binding of the conjugate to hydroxyapatite. The labels and methods can be utilized to detect deposits in eye tissue, such as the retina, brain tissue, or the like. Methods are also provided for utilizing the present labels to predict or diagnose a neurodegenerative disease, including age-related macular degeneration. Accordingly, some methods can predict or diagnose age-related macular degeneration, including early signs or advanced forms thereof, based on the presence of hydroxyapatite in a tissue sample obtained from a subject.


Find Patent Forward Citations

Loading…